1 for central post-stroke pain and neuropathic facial pain.

2 ilepsy and control subjects with intractable facial pain.

3 with 5 days of upper respiratory illness and facial pain.

4 h trigeminal stimulation triggers paroxysmal facial pain, affects defensive peripersonal space (DPPS)

5 ght-sided perimandibular swelling, recurrent facial pain and exposed necrotic bone after previous ext

6 an with diabetes mellitus who presented with facial pain and right eye proptosis.

7 d with CRS cases who reported smell loss and facial pain and/or pressure and had the weakest associat

8 /pressure; smell loss without pain/pressure; facial pain and/or pressure without smell loss; and both

9                     Paradoxically, headache, facial pain, and sleep disturbance occurred significantl

10 ression, but the rates of burning and aching facial pain, as reported on the last follow-up questionn

11 nts, who were referred to a university-based facial pain clinic, were asked to mark all painful sites

12 ostulated that the most commonly undiagnosed facial pain conditions include neuropathic and myofascia

13                                              Facial pain is a debilitating disorder if left untreated

14 , high fever and purulent nasal discharge or facial pain lasting for at least 3 consecutive days, or

15 9 degrees C) and purulent nasal discharge or facial pain lasting for at least 3 consecutive days, or

16 interference leads to spontaneous and evoked facial pain-like behavior in freely moving rats.

17  that among a great percentage of persistent facial pain patients the pain distribution is more wides

18 is symptoms-especially those with unilateral facial pain-regardless of duration of illness.

19 g" when compared with the 19% annual rate of facial pain symptoms.